DA Davidson Maintains Buy on Medifast, Lowers Price Target to $349
DA Davidson analyst Linda Bolton Weiser maintains Medifast (NYSE:MED) with a Buy and lowers the price target from $395 to $349.
Medifast Q3 EPS $3.56 Beats $3.08 Estimate, Sales $413.40M Beat $403.76M Estimate; Sees FY21 Sales $1.51B-$1.53B vs $1.52B Estimate, EPS $13.27-$13.96 vs $13.93 Estimate
Medifast (NYSE:MED) reported quarterly earnings of $3.56 per share which beat the analyst consensus estimate of $3.08 by 15.58 percent. This is a 22.34 percent increase over earnings of $2.91 per share from the same
Earnings Scheduled For November 4, 2021
Companies Reporting Before The Bell
• DISH Network (NASDAQ:DISH) is likely to report quarterly earnings at $0.91 per share on revenue of $4.45 billion.
Return on Capital Employed Overview: Medifast
After pulling data from Benzinga Pro it seems like during Q2, Medifast (NYSE:MED) earned $61.43 million, a 16.35% increase from the preceding quarter. Medifast also posted a total of $394.19 million in sales, a 15.71% increase since Q1.
Medifast Q2 EPS $3.96 Beats $3.31 Estimate, Sales $394.20M Beat $358.45M Estimate
Medifast (NYSE:MED) reported quarterly earnings of $3.96 per share which beat the analyst consensus estimate of $3.31 by 19.64 percent. This is a 102.04 percent increase over earnings of $1.96 per share from the same
Earnings Scheduled For August 4, 2021
Companies Reporting Before The Bell
• UroGen Pharma (NASDAQ:URGN) is projected to report earnings for its second quarter.
Understanding Medifast’s Ex-Dividend Date
On June 3, 2021, Medifast (NYSE:MED) declared a dividend payable on August 6, 2021 to its shareholders. Medifast also announced that shareholders on the company's books on or before June 22, 2021 are entitled to the dividend. The stock will then go ex-dividend 1 business day(s) before the record date.